Supplementary Table 3.
Expression Status of COL10A1Var1 and Canonical COL10A1 Across Lesions
| EAC (N = 219)a |
||
|---|---|---|
| Canonical COL10A1-positive | Canonical COL10A1-negative | |
| COL10A1Var1-positive | 53 (24.2%) | 79 (36.07%) |
| COL10A1Var1-negative | 1 (0.46%) | 86 (39.27%) |
| NDBE (N = 141)a | ||
|---|---|---|
| Canonical COL10A1-positive | Canonical COL10A1-negative | |
| COL10A1Var1-positive | 0 (0%) | 2 (1.42%) |
| COL10A1Var1-negative | 22 (15.6%) | 117 (82.98%) |
| HGD (N = 60)a | ||
|---|---|---|
| Canonical COL10A1-positive | Canonical COL10A1-negative | |
| COL10A1Var1-positive | 1 (1.67%) | 1 (1.67%) |
| COL10A1Var1-negative | 5 (8.33%) | 53 (88.33%) |
| SQ (N = 476)a | ||
|---|---|---|
| Canonical COL10A1-positive | Canonical COL10A1-negative | |
| COL10A1Var1-positive | 9 (1.89%) | 21 (4.41%) |
| COL10A1Var1-negative | 67 (14.08%) | 379 (79.62%) |
| GAST (N= 25)a | ||
|---|---|---|
| Canonical COL10A1-positive | Canonical COL10A1-negative | |
| COL10A1Var1-positive | 0 (0%) | 1 (4%) |
| COL10A1Var1-negative | 9 (36%) | 15 (60%) |
NDBE, nondysplastic Barrett’s esophagus.
a
Number of samples combined from both Discovery and Validation cohorts.